Disease Info Card

Benign Bone Neoplasm

Information about Benign Bone Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Benign Bone Neoplasm

Most recent studies have shown that Benign Bone Neoplasm shares some biological mechanisms with benign-neoplasm, bone-cysts, bone-neoplasms, cartilaginous-exostosis, chondroblastoma, chondrosarcoma, edema, exostoses, fibroma, giant-cell-tumors, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, osteoblastoma, osteoid-osteoma, osteoma, pain, spinal-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Benign Bone Neoplasm, and have been seen in publications frequently: Bone Remodeling, Cell Cycle, Coagulation, Endochondral Ossification, Enucleation, Exocytosis, Glycolysis, Inflammatory Response, Interphase, Localization, Metaphase, Mitosis, Ossification, Osteoclast Differentiation, Pathogenesis, Regeneration, Telomere Maintenance, Translation, Wound Healing

Quite a number of genes have been found to play important roles in Benign Bone Neoplasm, such as ACSBG1, ACTG1, APOH, CD33, CD34, CDKN2A, CXCL10, EXT1, EXT2, GUSB, HNRNPC, HSPD1, INVS, LMLN, POMT1, SS18L1, TNFRSF11A, TNFSF11, TP53, UCHL3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Benign Bone Neoplasm Related Genes

click to see detail information for each gene

ACSBG1 ACTG1 APOH
CD33 CD34 CDKN2A
CXCL10 EXT1 EXT2
GUSB HNRNPC HSPD1
INVS LMLN POMT1
SS18L1 TNFRSF11A TNFSF11
TP53 UCHL3